ID   PPAF_PHAVU              Reviewed;         459 AA.
AC   P80366; O24319;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   26-NOV-2014, sequence version 3.
DT   01-APR-2015, entry version 98.
DE   RecName: Full=Fe(3+)-Zn(2+) purple acid phosphatase {ECO:0000303|PubMed:8001554};
DE            Short=PAP {ECO:0000303|PubMed:8001554};
DE            EC=3.1.3.2 {ECO:0000269|PubMed:12054466, ECO:0000269|PubMed:22943065};
DE   AltName: Full=Iron(III)-zinc(II) purple acid phosphatase {ECO:0000305|PubMed:8001554};
DE   Flags: Precursor;
OS   Phaseolus vulgaris (Kidney bean) (French bean).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; fabids; Fabales; Fabaceae; Papilionoideae;
OC   Phaseoleae; Phaseolus.
OX   NCBI_TaxID=3885;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, ENZYME REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND BLOCKAGE OF N-TERMINUS.
RC   TISSUE=Seed {ECO:0000312|EMBL:CAA04644.1};
RX   PubMed=12054466; DOI=10.1016/S0003-9861(02)00046-2;
RA   Vogel A., Borchers T., Marcus K., Meyer H.E., Krebs B., Spener F.;
RT   "Heterologous expression and characterization of recombinant purple
RT   acid phosphatase from red kidney bean.";
RL   Arch. Biochem. Biophys. 401:164-172(2002).
RN   [2]
RP   PROTEIN SEQUENCE OF 28-459.
RC   TISSUE=Seed {ECO:0000303|PubMed:8001554};
RX   PubMed=8001554; DOI=10.1111/j.1432-1033.1994.tb20061.x;
RA   Klabunde T., Stahl B., Suerbaum H., Hahner S., Karas M.,
RA   Hillenkamp F., Krebs B., Witzel H.;
RT   "The amino acid sequence of the red kidney bean Fe(III)-Zn(II) purple
RT   acid phosphatase. Determination of the amino acid sequence by a
RT   combination of matrix-assisted laser desorption/ionization mass
RT   spectrometry and automated Edman sequencing.";
RL   Eur. J. Biochem. 226:369-375(1994).
RN   [3]
RP   PARTIAL PROTEIN SEQUENCE, AND GLYCOSYLATION AT ASN-108; ASN-136;
RP   ASN-170; ASN-238 AND ASN-423.
RC   TISSUE=Seed;
RX   PubMed=8125089; DOI=10.1111/j.1432-1033.1994.tb18628.x;
RA   Stahl B., Klabunde T., Witzel H., Krebs B., Steup M., Karas M.,
RA   Hillenkamp F.;
RT   "The oligosaccharides of the Fe(III)-Zn(II) purple acid phosphatase of
RT   the red kidney bean. Determination of the structure by a combination
RT   of matrix-assisted laser desorption/ionization mass spectrometry and
RT   selective enzymic degradation.";
RL   Eur. J. Biochem. 220:321-330(1994).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS), COFACTOR, SUBUNIT, AND ACTIVE
RP   SITE.
RX   PubMed=7770774; DOI=10.1126/science.7770774;
RA   Straeter N., Klabunde T., Tucker P., Witzel H., Krebs B.;
RT   "Crystal structure of a purple acid phosphatase containing a dinuclear
RT   Fe(III)-Zn(II) active site.";
RL   Science 268:1489-1492(1995).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS), COFACTOR, SUBUNIT,
RP   GLYCOSYLATION AT ASN-108; ASN-136; ASN-170; ASN-238 AND ASN-423,
RP   DISULFIDE BOND, AND ACTIVE SITE.
RX   PubMed=8683579; DOI=10.1006/jmbi.1996.0354;
RA   Klabunde T., Straeter N., Froehlich R., Witzel H., Krebs B.;
RT   "Mechanism of Fe(III)-Zn(II) purple acid phosphatase based on crystal
RT   structures.";
RL   J. Mol. Biol. 259:737-748(1996).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 34-459 IN COMPLEX WITH
RP   INHIBITOR, CATALYTIC ACTIVITY, COFACTOR, ENZYME REGULATION, SUBUNIT,
RP   DISULFIDE BOND, AND GLYCOSYLATION AT ASN-108; ASN-136; ASN-170 AND
RP   ASN-423.
RX   PubMed=22943065; DOI=10.1111/cbdd.12001;
RA   Feder D., Hussein W.M., Clayton D.J., Kan M.W., Schenk G.,
RA   McGeary R.P., Guddat L.W.;
RT   "Identification of purple acid phosphatase inhibitors by fragment-
RT   based screening: promising new leads for osteoporosis therapeutics.";
RL   Chem. Biol. Drug Des. 80:665-674(2012).
CC   -!- CATALYTIC ACTIVITY: A phosphate monoester + H(2)O = an alcohol +
CC       phosphate. {ECO:0000269|PubMed:12054466,
CC       ECO:0000269|PubMed:22943065}.
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875;
CC       Note=Binds 1 Fe cation per subunit. {ECO:0000269|PubMed:22943065,
CC       ECO:0000269|PubMed:7770774, ECO:0000269|PubMed:8683579};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:22943065,
CC       ECO:0000269|PubMed:7770774, ECO:0000269|PubMed:8683579};
CC   -!- ENZYME REGULATION: Inhibited by compounds CC24201, CC27209, and
CC       MO07123 (PubMed:22943065). Inhibited by the tetraoxoanions
CC       molybdate and phosphate (PubMed:12054466). Not inhibited by EDTA
CC       or tartrate (PubMed:12054466). {ECO:0000269|PubMed:12054466,
CC       ECO:0000269|PubMed:22943065}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 6.1. {ECO:0000269|PubMed:12054466};
CC   -!- SUBUNIT: Homodimer; disulfide-linked.
CC       {ECO:0000269|PubMed:22943065, ECO:0000269|PubMed:7770774,
CC       ECO:0000269|PubMed:8683579}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000303|PubMed:12054466}.
CC   -!- SIMILARITY: Belongs to the metallophosphoesterase superfamily.
CC       Purple acid phosphatase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ001270; CAA04644.1; -; mRNA.
DR   PDB; 1KBP; X-ray; 2.65 A; A/B/C/D=28-459.
DR   PDB; 2QFP; X-ray; 2.20 A; A/B/C/D=36-459.
DR   PDB; 2QFR; X-ray; 2.40 A; A/B=36-459.
DR   PDB; 3KBP; X-ray; 3.00 A; A/B/C/D=28-459.
DR   PDB; 4DHL; X-ray; 2.30 A; A/B/C/D=34-459.
DR   PDB; 4DSY; X-ray; 2.30 A; A/B/C/D=34-459.
DR   PDB; 4DT2; X-ray; 2.70 A; A/B/C/D=34-459.
DR   PDB; 4KBP; X-ray; 2.70 A; A/B/C/D=28-459.
DR   PDB; 4KKZ; X-ray; 2.20 A; A/B/C/D=34-459.
DR   PDBsum; 1KBP; -.
DR   PDBsum; 2QFP; -.
DR   PDBsum; 2QFR; -.
DR   PDBsum; 3KBP; -.
DR   PDBsum; 4DHL; -.
DR   PDBsum; 4DSY; -.
DR   PDBsum; 4DT2; -.
DR   PDBsum; 4KBP; -.
DR   PDBsum; 4KKZ; -.
DR   ProteinModelPortal; P80366; -.
DR   SMR; P80366; 36-459.
DR   BindingDB; P80366; -.
DR   ChEMBL; CHEMBL5670; -.
DR   UniCarbKB; P80366; -.
DR   BRENDA; 3.1.3.2; 4746.
DR   EvolutionaryTrace; P80366; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0003993; F:acid phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0008199; F:ferric iron binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0016311; P:dephosphorylation; IDA:GOC.
DR   Gene3D; 2.60.40.380; -; 1.
DR   Gene3D; 3.60.21.10; -; 1.
DR   InterPro; IPR004843; Calcineurin-like_PHP_apaH.
DR   InterPro; IPR029052; Metallo-depent_PP-like.
DR   InterPro; IPR008963; Purple_acid_Pase-like_N.
DR   InterPro; IPR015914; Purple_acid_Pase_N.
DR   InterPro; IPR025733; Purple_acid_PPase_C_dom.
DR   Pfam; PF00149; Metallophos; 1.
DR   Pfam; PF14008; Metallophos_C; 1.
DR   SUPFAM; SSF49363; SSF49363; 1.
DR   SUPFAM; SSF56300; SSF56300; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Hydrolase; Iron; Metal-binding; Secreted; Signal; Zinc.
FT   SIGNAL        1     22       {ECO:0000255,
FT                                ECO:0000303|PubMed:12054466}.
FT   CHAIN        23    459       Fe(3+)-Zn(2+) purple acid phosphatase.
FT                                {ECO:0000255,
FT                                ECO:0000303|PubMed:12054466}.
FT                                /FTId=PRO_0000114474.
FT   ACT_SITE    323    323       Proton donor.
FT                                {ECO:0000303|PubMed:7770774,
FT                                ECO:0000303|PubMed:8683579}.
FT   METAL       162    162       Iron. {ECO:0000269|PubMed:22943065,
FT                                ECO:0000269|PubMed:8683579}.
FT   METAL       191    191       Iron. {ECO:0000269|PubMed:22943065,
FT                                ECO:0000269|PubMed:8683579}.
FT   METAL       191    191       Zinc. {ECO:0000269|PubMed:22943065,
FT                                ECO:0000269|PubMed:8683579}.
FT   METAL       194    194       Iron. {ECO:0000269|PubMed:22943065,
FT                                ECO:0000269|PubMed:8683579}.
FT   METAL       228    228       Zinc. {ECO:0000269|PubMed:22943065,
FT                                ECO:0000269|PubMed:8683579}.
FT   METAL       313    313       Zinc. {ECO:0000269|PubMed:22943065,
FT                                ECO:0000269|PubMed:8683579}.
FT   METAL       350    350       Zinc. {ECO:0000269|PubMed:22943065,
FT                                ECO:0000269|PubMed:8683579}.
FT   METAL       352    352       Iron. {ECO:0000269|PubMed:22943065,
FT                                ECO:0000269|PubMed:8683579}.
FT   MOD_RES      23     23       Blocked amino end (Gly).
FT                                {ECO:0000269|PubMed:12054466}.
FT   CARBOHYD    108    108       N-linked (GlcNAc...); partial.
FT                                {ECO:0000269|PubMed:22943065,
FT                                ECO:0000269|PubMed:8125089,
FT                                ECO:0000269|PubMed:8683579}.
FT   CARBOHYD    136    136       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:22943065,
FT                                ECO:0000269|PubMed:8125089,
FT                                ECO:0000269|PubMed:8683579}.
FT   CARBOHYD    170    170       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:22943065,
FT                                ECO:0000269|PubMed:8125089,
FT                                ECO:0000269|PubMed:8683579}.
FT   CARBOHYD    238    238       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:8125089,
FT                                ECO:0000269|PubMed:8683579}.
FT   CARBOHYD    423    423       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:22943065,
FT                                ECO:0000269|PubMed:8125089,
FT                                ECO:0000269|PubMed:8683579}.
FT   DISULFID    372    372       Interchain. {ECO:0000269|PubMed:22943065,
FT                                ECO:0000269|PubMed:8683579}.
FT   CONFLICT    280    281       YS -> HI (in Ref. 2; AA sequence).
FT   CONFLICT    369    369       N -> D (in Ref. 2; AA sequence).
FT   HELIX        43     45       {ECO:0000244|PDB:2QFP}.
FT   STRAND       55     61       {ECO:0000244|PDB:2QFP}.
FT   STRAND       63     67       {ECO:0000244|PDB:2QFP}.
FT   STRAND       69     78       {ECO:0000244|PDB:2QFP}.
FT   STRAND       84     91       {ECO:0000244|PDB:2QFP}.
FT   STRAND       95     97       {ECO:0000244|PDB:2QFP}.
FT   STRAND      100    102       {ECO:0000244|PDB:2QFP}.
FT   STRAND      113    119       {ECO:0000244|PDB:2QFP}.
FT   STRAND      127    132       {ECO:0000244|PDB:2QFP}.
FT   STRAND      135    137       {ECO:0000244|PDB:2QFP}.
FT   STRAND      139    144       {ECO:0000244|PDB:2QFP}.
FT   STRAND      155    160       {ECO:0000244|PDB:2QFP}.
FT   HELIX       167    177       {ECO:0000244|PDB:2QFP}.
FT   STRAND      185    188       {ECO:0000244|PDB:2QFP}.
FT   HELIX       195    197       {ECO:0000244|PDB:2QFP}.
FT   HELIX       199    201       {ECO:0000244|PDB:2QFP}.
FT   HELIX       204    217       {ECO:0000244|PDB:2QFP}.
FT   STRAND      222    224       {ECO:0000244|PDB:2QFP}.
FT   HELIX       228    231       {ECO:0000244|PDB:2QFP}.
FT   HELIX       235    237       {ECO:0000244|PDB:2QFP}.
FT   HELIX       244    249       {ECO:0000244|PDB:2QFP}.
FT   HELIX       254    257       {ECO:0000244|PDB:2QFP}.
FT   STRAND      264    269       {ECO:0000244|PDB:2QFP}.
FT   STRAND      272    276       {ECO:0000244|PDB:2QFP}.
FT   HELIX       288    299       {ECO:0000244|PDB:2QFP}.
FT   TURN        302    304       {ECO:0000244|PDB:2QFP}.
FT   STRAND      307    311       {ECO:0000244|PDB:2QFP}.
FT   TURN        322    327       {ECO:0000244|PDB:2QFP}.
FT   HELIX       328    340       {ECO:0000244|PDB:2QFP}.
FT   STRAND      344    348       {ECO:0000244|PDB:2QFP}.
FT   STRAND      350    357       {ECO:0000244|PDB:2QFP}.
FT   STRAND      359    361       {ECO:0000244|PDB:2QFP}.
FT   STRAND      367    369       {ECO:0000244|PDB:2QFP}.
FT   STRAND      382    386       {ECO:0000244|PDB:2QFP}.
FT   TURN        391    393       {ECO:0000244|PDB:1KBP}.
FT   STRAND      407    411       {ECO:0000244|PDB:2QFP}.
FT   STRAND      415    421       {ECO:0000244|PDB:2QFP}.
FT   STRAND      423    433       {ECO:0000244|PDB:2QFP}.
FT   STRAND      442    448       {ECO:0000244|PDB:2QFP}.
FT   TURN        450    452       {ECO:0000244|PDB:2QFP}.
SQ   SEQUENCE   459 AA;  52857 MW;  CC379B7C1AE4D21A CRC64;
     MGVVKGLLAL ALVLNVVVVS NGGKSSNFVR KTNKNRDMPL DSDVFRVPPG YNAPQQVHIT
     QGDLVGRAMI ISWVTMDEPG SSAVRYWSEK NGRKRIAKGK MSTYRFFNYS SGFIHHTTIR
     KLKYNTKYYY EVGLRNTTRR FSFITPPQTG LDVPYTFGLI GDLGQSFDSN TTLSHYELSP
     KKGQTVLFVG DLSYADRYPN HDNVRWDTWG RFTERSVAYQ PWIWTAGNHE IEFAPEINET
     EPFKPFSYRY HVPYEASQST SPFWYSIKRA SAHIIVLSSY SAYGRGTPQY TWLKKELRKV
     KRSETPWLIV LMHSPLYNSY NHHFMEGEAM RTKFEAWFVK YKVDVVFAGH VHAYERSERV
     SNIAYKITNG LCTPVKDQSA PVYITIGDAG NYGVIDSNMI QPQPEYSAFR EASFGHGMFD
     IKNRTHAHFS WNRNQDGVAV EADSVWFFNR HWYPVDDST
//
